Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey
dc.authorid | Paydas, Semra/0000-0003-4642-3693 | |
dc.authorid | Yaşar, Hatime Arzu/0000-0002-0545-1383 | |
dc.authorid | Uysal, Mukremin/0000-0002-8524-0665 | |
dc.authorid | Kilickap, Saadettin/0000-0003-1637-7390 | |
dc.authorid | Cicin, Irfan/0000-0002-7584-3868 | |
dc.authorid | Eralp, Yesim/0000-0001-9603-4755; | |
dc.authorwosid | Paydas, Semra/F-3132-2018 | |
dc.authorwosid | Urvay, Semiha/AAM-2335-2021 | |
dc.authorwosid | TURHAL, NAZIM SERDAR/AAJ-4421-2020 | |
dc.authorwosid | Kucukoner, Mehmet/E-1162-2013 | |
dc.authorwosid | Sendur, Mehmet Ali Nahit/H-7555-2014 | |
dc.authorwosid | Yaşar, Hatime Arzu/HGC-5631-2022 | |
dc.authorwosid | Uysal, Mukremin/B-8956-2014 | |
dc.contributor.author | Kilickap, S. | |
dc.contributor.author | Ozturk, A. | |
dc.contributor.author | Karadurmus, N. | |
dc.contributor.author | Korkmaz, T. | |
dc.contributor.author | Yumuk, P. | |
dc.contributor.author | Cicin, I. | |
dc.contributor.author | Paydas, S. | |
dc.date.accessioned | 2024-06-12T11:09:27Z | |
dc.date.available | 2024-06-12T11:09:27Z | |
dc.date.issued | 2018 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.identifier.endpage | S478 | en_US |
dc.identifier.issn | 1556-0864 | |
dc.identifier.issn | 1556-1380 | |
dc.identifier.issue | 10 | en_US |
dc.identifier.startpage | S477 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/22795 | |
dc.identifier.volume | 13 | en_US |
dc.identifier.wos | WOS:000454014501235 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science Inc | en_US |
dc.relation.ispartof | Journal Of Thoracic Oncology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | NSCLC | en_US |
dc.subject | ALK Inhibitor | en_US |
dc.subject | Crizotinib | en_US |
dc.title | Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey | en_US |
dc.type | Conference Object | en_US |